Philip S Hammond

Title: Innovations of Philip S Hammond

Introduction

Philip S Hammond is an accomplished inventor based in Pinnacle, NC (US). He holds a total of six patents, showcasing his significant contributions to the field of pharmaceutical sciences. His work primarily focuses on compounds that target neuronal nicotinic receptors, which play a crucial role in various central nervous system disorders.

Latest Patents

Hammond's latest patents include innovative compounds such as nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes. These compounds are designed to exhibit selectivity for the α4β2 subtype of nicotinic receptors in the central nervous system. They have the potential to treat and prevent a wide variety of CNS disorders while minimizing adverse side effects. Another notable patent involves the synthesis and novel salt forms of (R)-3-((E)-pyrrolidin-3-yl)vinyl)-5-tetrahydropyran-4-yloxy)pyridine, which focuses on the commercial-scale production of these compounds for pharmaceutical use.

Career Highlights

Throughout his career, Hammond has worked with notable companies such as Targacept, Inc. and Attenua, Inc. His expertise in the field has led to significant advancements in the development of therapeutic compounds aimed at improving patient outcomes.

Collaborations

Hammond has collaborated with esteemed colleagues, including Scott R Breining and Yun-De Xiao, contributing to the advancement of research in his area of expertise.

Conclusion

Philip S Hammond's innovative work in the field of pharmaceutical sciences has led to the development of important compounds that hold promise for treating CNS disorders. His contributions continue to impact the medical community positively.